A clinical study of adults with NAFLD demonstrated an increased risk of progression to CKD in the group with a high-risk of fibrosis, which was accompanied by a decrease in IGF-1 [143]. The gene discussed is IGF1; the disease is metabolic dysfunction-associated steatotic liver disease.